Table 3.
Interaction effect among age and SARS-CoV2 infection on SAA levels.
Outcome | Age | SARS-CoV2 Infection |
Mean (95% CI) | p-Value |
p-Value for Interaction |
---|---|---|---|---|---|
SAA (ng/mL) |
mean − SD: 46 years | Negative | 47.1 (34.3; 64.7) | 0.1780 | 0.0087 |
Positive | 58.3 (42.4; 80.4) | ||||
mean: 59 years | Negative | 34.4 (26.2; 45.0) | <0.0001 | ||
Positive | 59.3 (44.8; 78.5) | ||||
mean + SD: 72 years | Negative | 25.1 (17.7; 35.5) | <0.0001 | ||
Positive | 60.3 (44.3; 82.3) |
Association between SAA and case control group was evaluated at three selected levels of age (mean-standard deviation (SD), mean, and mean + SD value). Data are expressed as adjusted geometric means and 95% confidence interval. Data are adjusted for gender, BMI, smoking, and antihypertensive medications. SAA, Serum amyloid A.